Перейти к содержанию

Healthequity, Inc. (HQY) stock: revenue, earnings & dividend

Healthequity, Inc. (HQY, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener HQY · Nasdaq Dienstleistungen US-UT

Key figures

Fiscal year
2025
Revenue
1.31 bn $
Revenue growth
9.5 %
Revenue growth 5y (p.a.)
12.4 %
Net income
215 m $
Net margin
16.4 %
Operating margin
24.6 %
Earnings per share (diluted)
2.46 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
3.38 bn $
Equity
2.11 bn $
Equity ratio
62.3 %
Return on equity
10.2 %
Cash
319 m $
Operating cash flow
457 m $
Free cash flow
455 m $
Shares outstanding
82,715,296

History

Revenue by fiscal year

2016 178 m $
2017 230 m $
2018 287 m $
2019 532 m $
2020 734 m $
2021 757 m $
2022 862 m $
2023 1,000 m $
2024 1.2 bn $
2025 1.31 bn $

Net income by fiscal year

2016 26.4 m $
2017 47.4 m $
2018 73.9 m $
2019 39.7 m $
2020 8.83 m $
2021 -44.29 m $
2022 -26.14 m $
2023 55.7 m $
2024 96.7 m $
2025 215 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.31 bn $215 m $2.46 $–457 m $
20241.2 bn $96.7 m $1.09 $–340 m $
20231,000 m $55.7 m $0.64 $–243 m $
2022862 m $-26.14 m $-0.31 $–151 m $
2021757 m $-44.29 m $-0.53 $–141 m $
2020734 m $8.83 m $0.12 $–182 m $
2019532 m $39.7 m $0.58 $–105 m $
2018287 m $73.9 m $1.17 $–113 m $
2017230 m $47.4 m $0.77 $–81.7 m $
2016178 m $26.4 m $0.44 $–45.6 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)